Latest News

GeoVax and Virometix to Collaborate on Immunotherapy Program for HPV Infections and Related Cancers
GeoVax Continues Expansion of International Collaborative Efforts for its Unique MVA-VLP Vaccine Tec...
Continue Reading...
GeoVax Reports 2018 Third Quarter Financial Results and Provides Corporate Update
ATLANTA, GA, November 8, 2018 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing ...
Continue Reading...
GeoVax Presenting at Upcoming Scientific Conferences
Plug & Play Platform Continues to be Recognized for Distinct Benefits ATLANTA, GA, November 7, ...
Continue Reading...